(Q81378656)
Statements
Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer (English)
Beth Karlan
Michael S Gordon
Charles Taylor
Ronald B Natale
David S Mendelson
Michael F Press
David E Allison
Mark X Sliwkowski
Gracie Lieberman
Stephen M Kelsey